Skip to content

A Study on the Effects and Safety of Red and Near-Infrared Light Therapy on Sleep Quality

Clinical study to explore the effects of red and near-infrared light therapy on sleep quality and safety

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0010839
Enrollment
16
Registered
2025-08-05
Start date
2025-08-18
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Red and near infrared radiator) : Apply red and near-infrared light therapy (iLED Pro) to the back of the neck and abdominal area four times a week (15 minutes per session) for four weeks. Befo

Sponsors

Cheonan Korean Medicine Hospital of Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults aged 19 to 64 years old 2. Individuals who have received sufficient explanation about the purpose, content, and clinical research equipment of the trial prior to participation, have voluntarily decided to participate in the clinical research, and have provided written consent 3. Individuals who can be followed up during the trial period

Exclusion criteria

Exclusion criteria: 1. Patients with sleep disorders (somnambulism, abnormal behavior during sleep, etc.) 2. Those who are currently taking medication for psychiatric disorders other than insomnia within the last three months 3. Pregnant women and nursing mothers 4. Others deemed unsuitable for the test by the examiner 5. Those diagnosed with circadian rhythm sleep disorders 6. Shift workers 7. Individuals who regularly take sleeping pills or sleep-inducing drugs 8. Individuals with skin allergies or abnormal reactions to sunlight 9. Individuals taking photosensitive drugs 10. Individuals with severe visual impairment, severe hearing impairment, or communication disorders that prevent them from undergoing intervention and efficacy evaluation 11. Individuals who have participated in other clinical studies involving intervention methods within 30 days of study participation

Design outcomes

Primary

MeasureTime frame
Leeds Sleep Evaluation Questionnaire(LSEQ)

Secondary

MeasureTime frame
General Sleep Disturbance Scale(GSDS);Pittsburgh Sleep Quality Index(PSQI);adverse events

Countries

Korea, Republic of

Contacts

Public ContactJae-hui Kang

Cheonan Korean Medicine Hospital of Daejeon University

rkd12@hanmail.net+82-41-521-7579

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026